News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
750,410 Results
Type
Article (45233)
Company Profile (335)
Press Release (704829)
Multimedia
Podcasts (112)
Webinars (19)
Section
Business (212381)
Career Advice (2112)
Deals (36522)
Drug Delivery (118)
Drug Development (82635)
Employer Resources (177)
FDA (16964)
Job Trends (15407)
News (357370)
Policy (33607)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2719)
Accelerated approval (31)
Adcomms (24)
Allergies (141)
Alliances (52619)
ALS (170)
Alzheimer's disease (1685)
Antibody-drug conjugate (ADC) (319)
Approvals (17223)
Artificial intelligence (548)
Autoimmune disease (146)
Automation (38)
Bankruptcy (366)
Best Places to Work (11930)
BIOSECURE Act (20)
Biosimilars (189)
Biotechnology (221)
Bladder cancer (159)
Brain cancer (56)
Breast cancer (639)
Cancer (4829)
Cardiovascular disease (401)
Career advice (1788)
Career pathing (36)
CAR-T (288)
CDC (45)
Celiac Disease (2)
Cell therapy (761)
Cervical cancer (36)
Clinical research (70327)
Collaboration (1751)
Company closure (4)
Compensation (1152)
Complete response letters (53)
COVID-19 (2795)
CRISPR (95)
C-suite (845)
Cystic fibrosis (149)
Data (6210)
Decentralized trials (2)
Denatured (43)
Depression (133)
Diabetes (500)
Diagnostics (6948)
Digital health (46)
Diversity (13)
Diversity, equity & inclusion (45)
Drug discovery (257)
Drug pricing (187)
Drug shortages (30)
Duchenne muscular dystrophy (230)
Earnings (91734)
Editorial (56)
Employer branding (22)
Employer resources (156)
Events (122067)
Executive appointments (995)
FDA (20100)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (23)
Funding (1503)
Gene editing (207)
Generative AI (49)
Gene therapy (614)
GLP-1 (983)
Government (4759)
Grass and pollen (7)
Guidances (385)
Healthcare (19592)
HIV (59)
Huntington's disease (44)
IgA nephropathy (81)
Immunology and inflammation (248)
Immuno-oncology (54)
Indications (104)
Infectious disease (3060)
Inflammatory bowel disease (192)
Inflation Reduction Act (14)
Influenza (114)
Intellectual property (250)
Interviews (327)
IPO (16986)
IRA (50)
Job creations (3830)
Job search strategy (1499)
JPM (60)
Kidney cancer (15)
Labor market (84)
Layoffs (561)
Leadership (32)
Legal (8170)
Liver cancer (93)
Longevity (14)
Lung cancer (643)
Lymphoma (374)
Machine learning (44)
Management (63)
Manufacturing (801)
MASH (162)
Medical device (14503)
Medtech (14557)
Mergers & acquisitions (20608)
Metabolic disorders (1266)
Multiple sclerosis (155)
NASH (16)
Neurodegenerative disease (313)
Neuropsychiatric disorders (86)
Neuroscience (2912)
Neurotech (1)
NextGen: Class of 2026 (6852)
Non-profit (4646)
Now hiring (65)
Obesity (592)
Opinion (271)
Ovarian cancer (165)
Pain (197)
Pancreatic cancer (226)
Parkinson's disease (283)
Partnered (34)
Patents (500)
Patient recruitment (480)
Peanut (58)
People (61100)
Pharmaceutical (70)
Pharmacy benefit managers (29)
Phase 1 (22088)
Phase 2 (30922)
Phase 3 (22954)
Pipeline (5130)
Policy (287)
Postmarket research (2583)
Preclinical (9454)
Press Release (71)
Prostate cancer (238)
Psychedelics (47)
Radiopharmaceuticals (296)
Rare diseases (828)
Real estate (6283)
Recruiting (69)
Regulatory (25050)
Reports (51)
Research institute (2524)
Resumes & cover letters (363)
Rett syndrome (27)
RNA editing (19)
RSV (77)
Schizophrenia (149)
Series A (250)
Series B (188)
Service/supplier (14)
Sickle cell disease (97)
Special edition (21)
Spinal muscular atrophy (158)
Sponsored (42)
Startups (3878)
State (2)
Stomach cancer (17)
Supply chain (105)
Tariffs (84)
The Weekly (67)
Vaccines (1026)
Venture capital (91)
Weight loss (382)
Women's health (88)
Worklife (18)
Date
Last 7 days (608)
Last 30 days (2045)
Last 365 days (30487)
2026 (2886)
2025 (30959)
2024 (36216)
2023 (41135)
2022 (52398)
2021 (56994)
2020 (55612)
2019 (48407)
2018 (36441)
2017 (33540)
2016 (33139)
2015 (39358)
2014 (32941)
2013 (27985)
2012 (30242)
2011 (30847)
2010 (28809)
Location
Africa (777)
Alabama (86)
Alaska (7)
Arizona (315)
Arkansas (14)
Asia (41912)
Australia (6964)
California (11371)
Canada (3275)
China (1113)
Colorado (482)
Connecticut (484)
Delaware (344)
Europe (91970)
Florida (1673)
Georgia (365)
Hawaii (3)
Idaho (64)
Illinois (880)
India (63)
Indiana (524)
Iowa (23)
Japan (427)
Kansas (129)
Kentucky (40)
Louisiana (27)
Maine (72)
Maryland (1389)
Massachusetts (8232)
Michigan (345)
Minnesota (640)
Mississippi (6)
Missouri (135)
Montana (34)
Nebraska (28)
Nevada (124)
New Hampshire (85)
New Jersey (3017)
New Mexico (30)
New York (2987)
North Carolina (1483)
North Dakota (10)
Northern California (5512)
Ohio (339)
Oklahoma (22)
Oregon (44)
Pennsylvania (2282)
Puerto Rico (23)
Rhode Island (48)
South America (1165)
South Carolina (66)
South Dakota (1)
Southern California (4428)
Tennessee (175)
Texas (1762)
United States (40473)
Utah (342)
Vermont (1)
Virginia (263)
Washington D.C. (82)
Washington State (938)
West Virginia (4)
Wisconsin (117)
Wyoming (2)
750,410 Results for "covalon technologies inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Covalon Presents Evidence-Backed Innovations Making a Difference for Critically Ill Children at APHON
September 25, 2025
·
6 min read
Press Releases
Covalon Announces Publication of Impactful VALGuard® Line Guard Clinical Study Demonstrating Significant Reduction in Central Line-Associated Blood Stream Infections (CLABSIs)
September 16, 2025
·
5 min read
Press Releases
Covalon Technologies Ltd. Poised for Strong Benefit From Positive US Tariff Outcome
April 3, 2025
·
3 min read
Press Releases
Covalon Reports Fifth Consecutive Quarter of Positive Earnings
May 28, 2025
·
16 min read
Business
Covalon Announces Profitable Second Quarter Fiscal 2024 Results
Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2024 second quarter results for the period ended March 31, 2024.
May 29, 2024
·
15 min read
Covalon Presents Compassionate Care Technology at the Infusion Nurses Society (INS) Annual Meeting & Exhibition in Kansas City, MO
Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its participation in the Infusion Nurses Society Annual Meeting and Exhibition, to be held in Kansas City, Missouri from Saturday, May 18 to Monday, May 20, 2024.
May 17, 2024
·
5 min read
Press Releases
DW Healthcare Partners Announces Sale of LKC Technologies to AMETEK, Inc.
February 3, 2026
·
2 min read
Press Releases
Covalon Announces Conference Call to Discuss Second Quarter Fiscal 2025 Financial Results
May 21, 2025
·
3 min read
Business
Covalon Announces Management Changes
Covalon Technologies Ltd. today announced the following management changes.
January 26, 2024
·
3 min read
Press Releases
Covalon Retains Financial and Strategic Advisor to Advise on Shareholder Value-Enhancing Opportunities
May 20, 2025
·
6 min read
1 of 75,041
Next
